Unnatural, Fluorescent Amino Acids
160.3 (1 C, Ci), 154.9 (1 C, C=N), 138.2 (1 C, C-5), 134.3 (1 C, Ci), [D6]DMSO): δ = 169.7 (1 C, C=O), 152.0 (1 C, C=N), 136.2 (1 C,
132.1 (1 C, Cα), 131.9 (2 C, Cm), 131.7 (1 C, C-2), 115.7 (2 C, Co), Car), 133.2 (1 C, Cα), 132.0 (1 C, C-2), 131.9 (1 C, Car), 130.9 (1 C,
114.6 (1 C, C-3), 112.1 (1 C, C-4), 111.7 (1 C, Cβ), 61.2 (1 C, C-5), 128.3, 127.2, 126.1, 125.6 (4 C, CHar), 125.4 (1 C, C-4), 111.4
NCH2), 56.4 (1 C, OMe), 54.5 (1 C, CH), 31.2 (1 C, CH2), 30.5 (1
C, CH2), 22.9 (1 C, CH2) ppm.
(1 C, C-3), 111.0 (1 C, Cβ), 60.4 (1 C, NCH2), 54.5 (1 C, CH), 30.8
(1 C, CH2), 29.9 (1 C, CH2), 29.6 (1 C, CH2), 23.1 (1 C, CH2), 21.8
(1 C, CH2) ppm. C21H25N3O2 (351.45): calcd. C 71.77, H 7.17, N
11.96; found C 71.88, H 7.21, N 11.86.
2-Amino-6-[(5-naphthalen-2-yl-1-vinylpyrrole-2-ylmethylidene)-
amino]hexanoic Acid (2d): From 0.25 g (1 mmol) of 1d 0.29 g (77%)
of 2d was obtained. Beige crystals. M.p. 208–211 °C (decomp.).
[α]2D3 = +3.2 (c = 0.02, CH CN). IR (KBr): ν = 3441, 3050, 2934,
˜
3
Acknowledgments
2858, 1636, 1582, 1515, 1452, 1407, 1355, 1325, 1302, 1273, 1257,
1215, 1195, 1158, 1130, 1046, 1016, 977, 959, 948, 926, 892, 858,
817, 779, 761, 742, 681, 665, 651, 632, 590, 552, 533, 474, 450 cm–1.
This work has been carried out under financial support of leading
1H NMR (400 MHz, [D6]DMSO): δ = 8.26 (s, 1 H, CH=N), 7.99 scientific schools by the President of the Russian Federation (Grant
3
3
(s, 1 H, Har), 7.90 (m, 3 H, Har), 7.61 (dd, JA-X = 8.6, JB-X
=
NSH-3230.2010.3)
15.6 Hz, 1 H, HX), 7.55 (m, 3 H, Har), 6.75 (d, 3J3-4 = 3.8 Hz, 1 H,
3-H), 6.48 (d, J3-4 = 3.8 Hz, 1 H, 4-H), 5.11 (d, JA-X = 8.6 Hz, 1
H, HA), 4.74 (d, JB-X = 15.6 Hz, 1 H, HB), 3.48 (m, 2 H, NCH2),
3
3
3
[1] a) D. K. Y. Poon, M. Schubert, J. Au, M. Okon, S. G. Withers,
L. P. McIntosh, J. Am. Chem. Soc. 2006, 128, 15388–15389; b)
M. Suzuki, K. Hanabusa, Chem. Soc. Rev. 2009, 38, 967–975.
[2] I. A. Taylor, M. Webb in Methods in Molecular Biology, vol.
148 (“DNA–Protein Interactions: Principles and Protocols”)
(Ed.: T. Moss), Humana Press Inc., Totowa, 2001, pp. 301–
314.
[3] Y. G. Zheng, J. Wu, Z. Chen, M. Goodman, Med. Res. Rev.
2008, 28, 645–687.
[4] W. S. Pierpoint, J. Gen. Virol. 1974, 25, 303–312.
[5] J. K. Shetty, J. E. Kinsella, Adv. Chem. 1982, 198, 169–198.
[6] T. Masuda, N. Ide, N. Kitabatake, Chem. Senses 2005, 30, 253–
264.
3.40 (br. s, 3 H, NH2, OH), 3.10 (m, 1 H, CH), 1.76 (m, 2 H, CH2),
1.57 (m, 2 H, CH2), 1.38 (m, 2 H, CH2) ppm. 13C NMR (100 MHz,
[D6]DMSO): δ = 169.7 (1 C, C=O), 152.0 (1 C, C=N), 136.8 (1 C,
C-5), 132.8, 132.4 (2 C, Car), 132.2 (1 C, Cα), 131.9 (1 C, Car), 131.8
(1 C, C-2), 129.8 (1 C, Car), 126.6–128.2 (7 C, Car), 115.1 (1 C, C-
3), 112.0 (1 C, C-4), 111.4 (1 C, Cβ), 60.6 (1 C, NCH2), 54.4 (1 C,
CH), 30.7 (1 C, CH2), 29.5 (1 C, CH2), 22.9 (1 C, CH2) ppm.
C23H25N3O2 (375.47): calcd. C 73.58, H 6.71, N 11.19; found C
73.78, H 6.65, N 11.36.
2-Amino-6-({[5-(2-thienyl)-1-vinylpyrrol-2-yl]methylene}amino)-
hexanoic Acid (2e): From 0.20 g (1 mmol) of 1e 0.30 g (90%) of 2e
[7] a) A. Bhaduri, K. P. Das, J. Dispersion Sci. Technol. 1998, 19,
435–449; b) W. G. McClung, D. L. Clapper, S.-P. Hu, J. L.
Brash, J. Biomed. Mater. Res. 2000, 49, 409–414.
was obtained. Beige crystals. M.p. 221–225 °C (decomp.). [α]2D3
=
+7.9 (c = 0.015, CH CN). IR (KBr): ν = 3437, 3056, 2987, 2925,
˜
3
[8] T. Berthelot, G. Laïn, L. Latxague, G. Déleris, J. Fluoresc.
2004, 14, 671–675.
[9] a) G. Witz, B. L. Van Duuren, J. Phys. Chem. 1973, 77, 648–
651; b) D. Klink, Q.-C. Yu, M. C. Glick, T. Scanlin, Mol. Ther.
2003, 7, 73–80; c) M. Link, P. Schulze, D. Belder, O. S. Wolf-
beis, Microchim. Acta 2009, 166, 183–188.
2858, 2821, 2132, 1624, 1583, 1517, 1473, 1452, 1414, 1352, 1327,
1290, 1222, 1198, 1157, 1121, 1033, 1001, 959, 909, 864, 846, 822,
772, 745, 687, 592, 532, 518, 493 cm–1
.
1H NMR (400 MHz,
3
[D6]DMSO): δ = 8.19 (s, 1 H, CH=N), 7.56 (d, J3Ј-4Ј = 5.1 Hz, 1
3
3
H, 3Ј-H), 7.34 (dd, JA-X = 8.6, JB-X = 15.9 Hz, 1 H, HX), 7.20
3
3
3
(d, J5Ј-4Ј = 3.4 Hz, 1 H, 5Ј-H), 7.10 (dd, J3Ј-4Ј = 5.1, J5Ј-4Ј
=
[10] a) P. M. Dewick, Medicinal Natural Products: A Biosynthetic
Approach, 2nd ed., Wiley, Chichester, 2001, p. 20; b) T. Sugi-
yama, A. Kittaka, H. Takayama, R. Kuroda, Nucleic Acids
Res. Suppl. 2001, 1, 175; c) H. Meixian, L. Ning, Y. Kemin,
Front. Chem. China 2006, 4, 369–373; d) S. Carganico, P. Ro-
vero, J. A. Halperin, A. M. Papini, M. Chorev, J. Pept. Sci.
2009, 15, 67–71; e) S. Khatua, J. Kang, J. OhHuh, C. S. Hong,
D. G. Churchill, Cryst. Growth Des. 2010, 10, 327–334.
[11] a) A. I. Mikhaleva, A. B. Zaitsev, A. V. Ivanov, E. Yu. Schmidt,
A. M. Vasil’tsov, B. A. Trofimov, Tetrahedron Lett. 2006, 47,
3693–3696; b) A. I. Mikhaleva, A. V. Ivanov, E. V. Skital’tseva,
I. A. Ushakov, A. M. Vasil’tsov, B. A. Trofimov, Synthesis
2009, 587–590.
[12] a) E. Abele, E. Lucevics, Heterocycles 2000, 53, 2285–2336; b)
A. I. Mikhaleva, E. Yu Schmidt, In: Selected methods for syn-
thesis and modification of heterocycles (Ed.: V. G. Kartsev), IBS
Press, Moscow, 2002, pp. 334–352; c) R. J. Tedeschi, “Acetyl-
ene” in: Encyclopedia of Physical Science and Technology, 3rd
ed. (Ed.: R. A. Meyers), Acad. Press, Inc., San Diego, 2004,
pp. 55–89; d) Z. Wang, in: Comprehensive Organic Name Reac-
tions and Reagents, Wiley, London, 2009, paragraph 626.
[13] a) A. M. Vasil’tsov, A. V. Ivanov, I. A. Ushakov, A. I. Mikh-
aleva, B. A. Trofimov, Synthesis 2007, 452–456; b) B. A. Trofi-
mov, A. V. Ivanov, E. V. Skital’tseva, A. M. Vasil’tsov, I. A.
Ushakov, K. B. Petrushenko, A. I. Mikhaleva, Synthesis 2009,
3603–3610; c) A. I. Mikhaleva, A. V. Ivanov, A. M. Vasil’tsov,
I. A. Ushakov, J. S. Ma, G. Yang, Chem. Heterocycl. Compd.
2008, 1117–1123.
3
3.4 Hz, 1 H, 4Ј-H), 6.71 (d, J3-4 = 3.9 Hz, 1 H, 3-H), 6.42 (d,
3J3-4 = 3.9 Hz, 1 H, 4-H), 5.33 (d, JA-X = 8.6 Hz, 1 H, HA), 5.08
3
3
(d, JB-X = 15.9 Hz, 1 H, HB), 3.46 (m, 2 H, NCH2), 3.40 (br. s, 3
H, NH2, OH), 3.08 (m, 1 H, CH), 1.73 (m, 2 H, CH2), 1.55 (m, 2
H, CH2), 1.35 (m, 2 H, CH2) ppm. 13C NMR (100 MHz, [D6]-
DMSO): δ = 169.7 (1 C, C=O), 151.9 (1 C, C=N), 133.8 (1 C, C-
2Ј), 132.1 (1 C, Cα), 132.0 (1 C, C-5), 129.9 (1 C, C-2), 127.7 (1 C,
C-3Ј), 127.5 (1 C, C-4Ј), 126.7 (1 C, C-5Ј), 114.1 (1 C, C-3), 113.9
(1 C, Cβ), 112.1 (1 C, C-4), 61.1 (1 C, NCH2), 54.3 (1 C, CH), 31.1
(1 C, CH2), 30.6 (1 C, CH2), 23.2 (1 C, CH2) ppm. C17H21N3O2S
(331.43): calcd. C 61.61, H 6.39, N 12.68; found C 61.89, H 6.11,
N 12.82.
2-Amino-6-{[(1-vinyl-4,5-dihydrobenzo[g]indol-2-yl)methylene]-
amino}hexanoic Acid (2f): From 0.22 g (1 mmol) of 1f 0.30 g (85%)
of 2f was obtained. Beige crystals. M.p. 206–210 °C (decomp.).
[α]2D3 = +5.5 (c = 0.01, CH CN). IR (KBr): ν = 3446, 3055, 2931,
˜
3
1628, 1603, 1583, 1515, 1478, 1439, 1407, 1358, 1324, 1308, 1294,
1254, 1194, 1158, 1135, 1097, 1046, 1026, 980, 916, 808, 775, 757,
1
736, 712, 668, 652, 509, 467, 442, 421 cm–1. H NMR (400 MHz,
3
[D6]DMSO): δ = 8.18 (s, 1 H, CH=N), 7.55 (dd, JA-X = 8.3,
3JB-X = 15.6 Hz, 1 H, HX), 7.59 (m, 1 H, Har), 7.27 (m, 1 H, Har),
7.18 (m, 1 H, Har), 7.10 (m, 1 H, Har) 6.60 (s, 1 H, 3-H), 5.38 (d,
3
3JA-X = 8.3 Hz, 1 H, HA), 5.18 (d, JB-X = 15.6 Hz, 1 H, HB), 3.46
(m, 2 H, NCH2), 3.40 (br. s, 3 H, NH2, OH), 3.10 (m, 1 H, CH),
2.78 (m, 2 H, CH2), 2.54 (m, 2 H, CH2), 1.72 (m, 2 H, CH2), 1.54
(m, 2 H, CH2), 1.36 (m, 2 H, CH2) ppm. 13C NMR (100 MHz,
[14] a) R. M. Freidinger, J. Org. Chem. 1985, 50, 3631–3633; b) R.
Alsfasser, R. Van Eldik, Inorg. Chem. 1996, 35, 628–636; c) E.
Eur. J. Org. Chem. 2010, 4554–4558
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4557